Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease ; volume:20 ; number:1 ; day:9 ; month:1 ; year:2020 ; pages:1-6 ; date:12.2020
BMC cardiovascular disorders ; 20, Heft 1 (9.1.2020), 1-6, 12.2020
- Creator
-
Zhen, Yanhua
Chang, Zhihui
Liu, Zhaoyu
Zheng, Jiahe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-019-01314-1
- URN
-
urn:nbn:de:101:1-2020041500462010329798
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhen, Yanhua
- Chang, Zhihui
- Liu, Zhaoyu
- Zheng, Jiahe
- SpringerLink (Online service)
Other Objects (12)
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for femoropopliteal artery disease : : the chronic total occlusion cohort in the IN.PACT global study
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study
Drug-coated balloon treatment of femoropopliteal lesions typically excluded from clinical trials : : 12-month findings from the IN.PACT global study
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for femoropopliteal artery disease : : the chronic total occlusion cohort in the IN.PACT global study
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study
Drug-coated balloon treatment of femoropopliteal lesions typically excluded from clinical trials : : 12-month findings from the IN.PACT global study
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for femoropopliteal artery disease : : the chronic total occlusion cohort in the IN.PACT global study
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study